Zobrazeno 1 - 10
of 636
pro vyhledávání: '"transarterial chemoembolization (TACE)"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background A majority of esophageal carcinoma patients are diagnosed at an advanced stage and are no longer suitable for surgical resection. Drug-eluting beads transarterial chemoembolization (DEB-TACE) with oxaliplatin-loaded CalliSpheres b
Externí odkaz:
https://doaj.org/article/0d5652cdfd27419dbae2e663234f0528
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Hepatocellular carcinoma (HCC) is a common malignant tumor, and glutamine is vital for tumor cells. The role of glutamine transporter SLC1A5 in tumor progression and transarterial chemoembolization (TACE) efficacy is under study.
Externí odkaz:
https://doaj.org/article/fda1a8b24d754d42a359bc5deab8d901
Autor:
Yuanxun Yue, Zhizhong Ren, Yaqin Wang, Ying Liu, Xiaowei Yang, Tianxiao Wang, Yating Bai, He Zhou, Qian Chen, Sujun Li, Yuewei Zhang
Publikováno v:
Immunity, Inflammation and Disease, Vol 12, Iss 9, Pp n/a-n/a (2024)
Abstract Background Myeloid‐derived suppressor cells (MDSCs) play a pivotal role in immunosuppression and tumor progression in hepatocellular carcinoma (HCC). While various treatments like surgical resection, ablation, and radiotherapy have been st
Externí odkaz:
https://doaj.org/article/d55489f6463746f0ae3e78ff7a863329
Autor:
Ryosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, Masashi Tamura, Takaya Tabuchi, Akihiro Yamaguchi, Shigeo Hayatsu, Jun Koizumi, Keisuke Ojiro, Hitomi Hoshi, Fumihiko Kaneko, Rei Morikawa, Fumie Noguchi, Karin Yamataka, Shingo Usui, Hirotoshi Ebinuma, Osamu Itano, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masanori Inoue, Seishi Nakatsuka, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Development of subclassification of intermediate-stage hepatocellular carcinoma (HCC) by treatment suitability is in demand. We aimed to identify predictors that define treatment refractoriness against locoregional(transarterial chemoemboliz
Externí odkaz:
https://doaj.org/article/21ca3054d1b84f30a5eee69eb46e472a
Autor:
Jiawei Lin, Jie Li, Yifan Kong, Junhui Yang, Yunjie Zhang, Guoqing Zhu, Zhijie Yu, Jinglin Xia
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Patients with hepatocellular carcinoma (HCC) who undergo transarterial chemoembolization (TACE) may have varied outcomes based on their liver function and tumor burden diversity. This study aims to assess the prognostic significan
Externí odkaz:
https://doaj.org/article/aabf42af549d4368b52197e1a087ea5d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThis study aimed to assess the effectiveness and safety of vascular intervention combined with lenvatinib versus vascular intervention alone in the treatment of advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT),
Externí odkaz:
https://doaj.org/article/cf9afd8088554c75b18d5af18a3e1af3
Autor:
Zhi-Hai Wu, Hai-Feng Zhang, Jun-Yan Li, Yi-Rui Diao, Man-Jing Huang, Dong-Yang Gao, Chang-Hao Liang, Zhi-Qiang Luo
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: The effectiveness and safety of using Brucea javanica oil (BJO) in combination with Transarterial Chemoembolization (TACE) for liver cancer treatment are subjects of debate. This study aims to assess the comparative effectiveness and safe
Externí odkaz:
https://doaj.org/article/71a7ba57ff0e4b57a98a8c20b7e7d43b
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background/ObjectiveTreatment of hepatocellular carcinoma (HCC) with ablation alone often results in high rates of recurrence and metastasis, reaching up to 25.9% within two years. Therefore, this study aimed to examine the efficacy and safety of tra
Externí odkaz:
https://doaj.org/article/5ecb6266d7a54433b785d015ae9a2b73
Publikováno v:
Liver Research, Vol 7, Iss 2, Pp 108-115 (2023)
Local ablation technologies, such as radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation, have become a standard treatment option for hepatocellular carcinoma (HCC) less than 5 cm in size, particularly in individuals who are not
Externí odkaz:
https://doaj.org/article/5beb5897be63490a8bf4fc5a28a68d9f
Autor:
Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11513-11524 (2023)
Abstract Background There is no consensus on the optimal regimen for unresectable recurrent hepatocellular carcinoma (HCC), so this retrospective study aimed to evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with
Externí odkaz:
https://doaj.org/article/6862c0cf51ad41c4a4df7fb2b3c55385